GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Cyclically Adjusted PS Ratio

Abaxis (Abaxis) Cyclically Adjusted PS Ratio : (As of May. 06, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abaxis Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Abaxis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Cyclically Adjusted PS Ratio Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abaxis's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Abaxis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abaxis's Cyclically Adjusted PS Ratio falls into.



Abaxis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Abaxis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2018 is calculated as:

For example, Abaxis's adjusted Revenue per Share data for the three months ended in Mar. 2018 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2018 (Change)*Current CPI (Mar. 2018)
=2.893/105.2895*105.2895
=2.893

Current CPI (Mar. 2018) = 105.2895.

Abaxis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200806 1.097 92.320 1.251
200809 1.241 92.307 1.416
200812 1.211 88.697 1.438
200903 1.180 89.744 1.384
200906 1.325 91.003 1.533
200909 1.341 91.120 1.550
200912 1.371 91.111 1.584
201003 1.478 91.821 1.695
201006 1.536 91.962 1.759
201009 1.555 92.162 1.776
201012 1.570 92.474 1.788
201103 1.629 94.283 1.819
201106 1.559 95.235 1.724
201109 1.774 95.727 1.951
201112 1.721 95.213 1.903
201203 1.932 96.783 2.102
201206 1.891 96.819 2.056
201209 1.984 97.633 2.140
201212 2.229 96.871 2.423
201303 1.985 98.209 2.128
201306 1.913 98.518 2.044
201309 2.031 98.790 2.165
201312 1.814 98.326 1.942
201403 1.426 99.695 1.506
201406 1.946 100.560 2.038
201409 2.224 100.428 2.332
201412 2.463 99.070 2.618
201503 2.262 99.621 2.391
201506 2.320 100.684 2.426
201509 2.448 100.392 2.567
201512 2.310 99.792 2.437
201603 2.490 100.470 2.609
201606 2.543 101.688 2.633
201609 2.574 101.861 2.661
201612 2.316 101.863 2.394
201703 2.538 102.862 2.598
201706 2.536 103.349 2.584
201709 2.559 104.136 2.587
201712 2.589 104.011 2.621
201803 2.893 105.290 2.893

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abaxis  (NAS:ABAX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Abaxis Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Abaxis's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020